Skip to main content
Home
  • 服务
    服务

    我们的服务涵盖产品开发和商业化的整个生命周期,既适用于小型本地试验,也适用于大型全球项目。

    Read More
    临床研究服务 商业定位 咨询服务 早期服务 战略性解决方案 语言服务 实验室服务 医学影像服务 真实世界洞察 研究中心及患者解决方案
    clinical-trials-china.jpeg
    COVID-19的临床试验

    Clinical trials during COVID-19.

    clinical-trials-china-2.jpeg
    研究中心和患者

    研究中心和患者识别,入组和参与

  • 治疗领域
    治疗领域

    我们在广泛的治疗领域拥有丰富的经验。我们管理所有主要地区的研究,与世界领先的研究人员建立了稳固的工作关系。

    Read More
    心血管系统 细胞和基因疗法(CGT) 中枢神经系统 内分泌与代谢疾病 感染性疾病 内科与免疫学 医疗器械 肿瘤学 儿科学 罕见病与孤儿病 移植免疫学 女性健康
    icon-china-mega-menu-image.jpeg
    疫苗

    ICON 领导了 18 种疫苗的开发,获得了 FDA/EMA 的批准,其中包括世界上第一个获批的 COVID-19 疫苗

    icon-china-mega-menu-image-2.jpeg
    治疗领域洞察

    ICON 的治疗专家定期为行业出版物内容做出贡献。

  • 加入我们
  • 新闻和活动
  • ICON中国
    ICON中国
    Read More
    ICON中国 公司历史 我们的荣誉 Leadership 联系我们
    esg-mdd.jpg
    环境、社会与公司治理(ESG)

    ICON Cares 代表我们致力于关爱每一个人、环境与社区,并带来积极改变的承诺。

    healthcare-intelligence-video-poster.png
    医疗智能赋能

    推动临床研究不断前行

  • 中国大陆办公室
  • 商务合作
  1. Home
  2. 新闻和活动
  3. 活动一览
  4. Webinars
  5. Optimise Medical Publishing and Avoid “Predatory Journals”

Optimise Medical Publishing and Avoid “Predatory Journals”

Learn Tips and Tools to Enhance your Medical Publication Efforts

  • Date 9 May 2017
    Time 11:00 - 12:00
    Location Webinar
    Timezone America/Bogota

On-Demand Webinar Archive

To access the archived recording of this webinar, visit our webinar channel and complete a one time only form. This will give you access to our entire library of archived webinars.

Access Webinar Archive

Join us to learn tips and tools to enhance your medical publication efforts and to help avoid so-called “predatory journals”. We’ll discuss the growth of open access publishing and the precautions you can take to avoid falling into costly and career damaging traps. Learn best practices and tools to:

  • Understand key attributes of true publication models so that you can differentiate between sanctioned and possible predatory journals/publishers.
  • Identify credible publishers and understand how they operate.
  • Create a personal list of possible predatory publishers to avoid future entrapments

Open access journals are scholarly publications, available across the internet. They are freely accessible, with no subscription costs. From 2012 to 2017, the number of open access journals increased from 4,034 to 9,405. [1]

While open access journals bring clear cost and accessibility advantages, it is important for authors to be able to accurately assess the quality and reputation of any potential publisher.

What are predatory publishers?

Predatory publishers are profiteering individuals or companies, who use the open access publishing model to take advantage of and exploit authors, by charging them article processing fees without providing the high quality editorial services associated with legitimate journals [2]. The term “predatory publisher” was first coined by Jeffrey Beall, who tracked them on his Scholarly Open Access blog from 2012 until January 2017.

How prevalent are predatory journals?

The number of predatory journals appears to be growing with open access journals having cropped up across the Internet. They appear to be legitimate, with websites similar to those of any typical scholarly publisher: editorial boards supported by well-respected scientists, claims of rigorous peer review and indexing in the most prominent databases. However, many young and inexperienced researchers all over the world have been deceived, losing both money and reputation. This problem is also increasing to disproportionally affect researchers in developing countries, particularly for scientists in areas with relatively low levels of publication literacy, training, and support.

[1] Directory of Open Access Journals (DOAJ)". DOAJ. Retrieved 15 March 2017.
[2] Beall, J. (2016) Best practices for scholarly authors in the age of predatory journals. The Annals of The Royal College of Surgeons of England 98(2), 77-79.

Presenters

Jeffrey Beall

Scholarly Communications Librarian and Associate Professor, University of Colorado Denver

Jeffrey’s work includes informing the scholarly community regarding new and evolving aspects of scholarly communication, including open access publishing, author and publisher misconduct, and scholarly publishing ethics. His research and writing has been published in The Journal of Academic Librarianship, Cataloging & Classification Quarterly, College & Research Libraries, and Nature. He operated Scholarly Open Access, which highlighted lists of predatory journals/publishers, misleading metrics companies, and hijacked journals. He began his library career at Harvard University, and earned his MS Library Science from the University of North Carolina.            

Janet Galliera

Executive Director Business Development, PubsHub, an ICON plc company

Janet has 18 years of experience in medical communications. She currently manages the PubsHub technology suite of web-based solutions. PubsHub continually sets new standards with powerful scientific data management tools. She is an active member of the International Society for Medical Publication Professionals (ISMPP) and was chair of the IMSPP workshops from 2008 to 2012.

 

Nicolle Watts

Sr. Director RWE Technology, ICON

Nicolle manages PubsHub Journals & Congresses, a web-based research tool that provides users with the most up-to-date and accurate submission information for 7000+ medical publications and conferences. Prior to joining PubsHub in 2013, Nicolle earned a BS in Library Science from the University of Kutztown with a focus in Informational Technology. 

Target Audience

  • Medical researchers
  • Medical publication professionals
  • Investigators
  • Research scientists
  • Key opinion leaders
  • University library professionals
  • Research organizations
  • Medical communication professionals
  • Pharmaceutical, Biotech, and Medical Device professionals
In this section
In this section
  • In the News
  • Press releases
  • 活动一览
    • Industry events
    • Webinars
    • Workshops
  • DIA China 2022

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media
Site Branding
    ICON plc
  • Contact
  • Results & Reports
For Clients
  • 我们的服务
  • 治疗领域
ICON for
  • 新 闻
  • 加入我们
News & Events
  • 中国大陆办公室
  • 商务合作
Socials
  • WeChat QR code

Legal Footer

  • © 2025 ICON plc
  • Disclaimer
  • Privacy
  • Cookies
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption